Drug Research
NeuroRx awarded FDA Fast Track Designation for first drug regimen targeting suicide in bipolar depression
NeuroRX , Acute Suicidal Ideation and Behavior (ASIB) , NRX-100 (ketamine HCl) , NRX-100 (ketamine HCl) , NeuroRx, a clinical stage biopharmacompany developing the...
Press Releases
mProve Health and Greenphire Partner to Delivera First-of-its-Kind Patient Engagement Solution
mProve Health, a leading provider of mobile technologies for patient engagement and electronic clinical outcome assessments (eCOA), andGreenphire, the global leader in clinical payment...
Press Releases
FDA approves Mylotarg for treatment of acute myeloid leukemia
Pfizer Inc. announced that the U.S. Food and Drug Administration approved MYLOTARG™ (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML),...
Clinical Trials
Presented in VIVA Late Breaking Clinical Trials Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data
Medtronic plc data announced reinforce the durability and safety of the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients with peripheral arterial disease (PAD). ...
News
FormulationX To Debut At INTERPHEX 2018
International Pharmaceutical Expo the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, today announced FormulationX will debut...
Production & Manufacturing
Commercial Manufacturing Agreement With US WorldMeds For Lofexidine Signed By Catalent
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products announced it has...
Press Releases
Aquavit Pharmaceuticals Adds New Patent To Its High-Tech Medical Portfolio
Aquavit Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office has issued a patent for Apollo Technology, System and Method for Personalized...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read